Setting and study participation. This single-center, observational, prospective cohort study was performed in the Neuro Intensive Care Unit (NICU). The study was performed according to the Declaration of Helsinki and was approved by the Regional Committee on Health Research Ethics for Southern Denmark (S-20190107), the Danish Data Protection Agency (20/4618) and in agreement with current local and national guidelines and regulations. Participants were included from September 2020 to May 2021. Given the nature of the study, unconscious patients could be included initially without their personal consent in accordance with approved study protocol. Informed consent was obtained from next-of-kin either prior to or after the fundoscopy was performed. Patients who regained consciousness were asked for consent as well.
The inclusion criteria were patients aged ≥18 admitted to the NICU who underwent invasive pressure neuromonitoring with either external ventricular drainage (EVD) or an intraparenchymal pressure monitor (IPPM). All participants had a Glasgow Coma Score of 8 or less.
Retinal videos of both eyes were captured daily. The ICP was recorded with a standard webcam pointed at the patient monitor. ICP and A/V ratio were then correlated according to specific time stamps. No mydriatic drugs were used. The IOP was obtained after each video session. Clinical and demographic data were collected from the electronic patient records as shown in Table 1. There were no adverse events reported following the fundoscopy.
Fundoscopies were performed using the Epicam M camera (Epipole Ltd., Rosyth, UK), which is CE-marked and compliant with Quality Management Software with ISO 13485. The Epicam is a handheld monochromatic sensor image camera that produces serial still images (15 images/second) of 1280 x 1024 pixels and can be manually focused (± 15 diopters). The videos were obtained using designated Epicam software (Epicam viewer software 3.1.1., Epipole Ltd.). IOP was obtained by a CE-marked ic100 tonometer TA011 (Icare Finland Oy, Finland) that was approved by the Reduction of Hazardous Substances in Electrical and Electronic Equipment (RoHS) Directive 2011/65/EU and has an accuracy of ± 1.2 mmHg up to 20 mmHg and ± 2.2 mmHg for > 20 mmHg. Both tonometry and fundoscopy was performed by the same operator.
Blinding. Fundoscopy and video analysis was done by separate individuals to ensure sufficient blinding and bias minimization. The fundoscopy operator matched each patient to the corresponding ICP acquired from the webcam data and performed statistics in collaboration with OPEN, SDU.
Retinal video analysis. Retinal video processing and analysis was performed by an external company (Statumanu ICP ApS, Denmark). StatuManu was given access to pseudo anonymized data only. Retinal video analysis was performed using a deep learning model which was trained on more than 200,000 fundus and non-fundus images. It is partly based on an image classifier called Efficientnet(20). The video recordings had a frame rate of 15 frames/second. The deep learning algorithm separated the videos into frames. It categorized each frame as ‘fundus’ or ‘no fundus’, based on the whether the optic disc and retinal vessels were present.
The optic disc was identified using ‘YOLOv7 object detection model’. Images without the optic disc present were discarded. Blood vessels in the remaining images were segmented using a deep learning vessel segmentation model. The highest quality image was chosen as a reference image, and its quality was assessed by an Edge Detection Filter (Tenengrad Gradient Magnitude) on a 1.5height/width crop around the optic disc. The remaining vessel segmentations were aligned to match the reference image.
The measurement points on each vessel were determined using a deep learning algorithm (Human Pose Estimation)(15). This algorithm had been retrained on retinal fundus images with marked measurement points to identify measurement points instead of poses.
Calculating vessel width and area. Using the defined measurement points, the widths of each vessel were calculated (Fig. 1). Using the calculated width, the area of a vessel at the point of a cross section could also be calculated:
$$\:Are{a}_{vessel}=\pi\:{\left(\frac{width}{2}\right)}^{2}$$
The ratio between the retinal artery and vein was calculated as the ratio between the areas of the two vessels:
$$\:A{V}_{area}=\left(\frac{{\left(\frac{arter{y}_{width}}{2}\right)}^{2}}{{\left(\frac{vei{n}_{width}}{2}\right)}^{2}}\right)$$
The A/V ratio was calculated for each measurement point and correlated with ICP according to time stamps.
Statistical considerations. The data analysis was performed using Stata 17 (StataCorp LLC, College station, Texas, USA). Patients’ A/V ratio differs from one another as shown in our previous study(2) hence we used a mixed-effect linear regression model for the hierarchical structured data. The correlations between ICP, IOP and A/V ratio from the pooled data were assessed. Furthermore, the A/V ratio was correlated with ICP for ICP≤IOP and ICP > IOP for visualization. The two slopes were then compared using a Wald test to investigate whether ICP > IOP or ICP > 15 mmHg correlated better with the A/V ratio.